ACE2 and cancer: Age- and gender-related ACE2 expression varied by cancer type, with significantly increased ACE2 expression in patients under 65 years for colorectal, gastric, and ovarian surface epithelial tumors, compared to patients 65 years and older (Supplementary Table 2).